A diabetes drug called dapagliflozin may help protect the hearts of diabetic rats and mice after a heart attack by making them pee out more sugar and easing the strain on their hearts.
Evidence from Studies
Supporting (0)
Community contributions welcome
Contradicting (2)
Community contributions welcome
The study shows that dapagliflozin helps protect the heart’s tiny blood vessels after a heart attack by fixing calcium and cell structure problems, not by making the body pee out more sugar or reducing heart strain like the claim says.
Dapagliflozin attenuates post-infarction fibrosis via cardiomyocyte protection and fibroblast inhibition.
The study shows that dapagliflozin helps heal the heart after a heart attack by reducing stress and inflammation in heart cells, not by making the heart work less or flushing out more sugar — so the reason given in the claim is wrong.
Gold Standard Evidence Needed
According to GRADE and EBM methodology, here is what ideal scientific evidence would look like to definitively prove or disprove this specific claim, ordered from strongest to weakest evidence.